The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
ID: 352285Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at facilitating the transition of mentored, non-independent cancer researchers to independent faculty positions. This funding opportunity provides financial support for salary and research expenses for up to three years, encouraging early-career scientists to develop their independent research programs focused on cancer research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Hispanic-serving Institutions, and various community-based organizations, with applications opening on May 12, 2024, and a closing date of November 12, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-117.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The NCI Transition Career Development Award (K22) is a funding opportunity by the National Cancer Institute (NCI) under the Department of Health and Human Services. This award aims to facilitate the transition of mentored, non-independent cancer researchers to independent faculty positions by providing financial support for salary and research expenses for up to three years. The program encourages early-career scientists to develop their independent research programs, with a strong emphasis on addressing cancer research needs. To be eligible, candidates should have a doctorate and at least two years but no more than eight years of postdoctoral training. Applications can be submitted starting May 12, 2024, with various review cycles and deadlines outlined. Each applicant must show the feasibility of their proposed research and commitment to a career in cancer research. The outlined criteria for review include the candidate’s experience, the career development plan, and the proposed research’s scientific merit. Institutions must demonstrate a commitment to supporting the candidate’s transition to independence. The framework provided in this announcement highlights the NIH's strategy to cultivate a diverse pool of scientists capable of advancing cancer research and improving public health.
    Similar Opportunities
    NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22), a federal grant aimed at assisting postdoctoral fellows and individuals in equivalent positions from diverse backgrounds to transition into independent research roles in cancer research. This initiative seeks to enhance diversity within the NCI-funded cancer research workforce, specifically targeting groups underrepresented in the biomedical, behavioral, and clinical sciences, and provides up to three years of salary and research support for candidates who secure tenure-track faculty positions. The program emphasizes the importance of a diverse scientific team in addressing public health issues and requires applicants to have a terminal doctoral degree, a minimum of two years of postdoctoral training, and a clear mentorship structure, while excluding proposals that involve leading independent clinical trials. Interested applicants can find more information and apply before the closing date of January 7, 2025, by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visiting the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-301.html.
    NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Career Transition Award (K22), a federal grant aimed at facilitating the transition of mentored postdoctoral researchers to tenure-track faculty positions while advancing the mission of the National Institute on Aging (NIA). This three-year grant provides salary and research support for candidates who secure a faculty position within 12 months of award approval, emphasizing the importance of a robust career development plan aligned with NIA's research priorities. The program underscores the government's commitment to fostering a diverse scientific workforce in health research, with eligibility extending to various institutions, including historically black colleges and universities and tribal colleges. Interested applicants must submit their proposals by November 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required), aimed at supporting postdoctoral fellows from underrepresented backgrounds in transitioning to independent research positions in cancer research. This grant provides "protected time" through salary and research support for three years, enabling candidates to lead an independent clinical trial or feasibility study while fostering diversity within the NCI-funded workforce. The program is crucial for addressing significant health disparities and encourages applications from historically underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds. Interested applicants must adhere to the eligibility criteria outlined in the funding opportunity announcement, with applications due by January 7, 2025. For further inquiries, candidates can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting diverse candidates transitioning from postdoctoral roles to independent research positions in cancer research. This grant provides financial support for up to three years, covering salary and research costs, specifically targeting senior postdoctoral fellows and individuals in equivalent positions who have completed relevant training and hold early-stage investigator status. The initiative emphasizes the importance of diversity in the biomedical workforce, encouraging applications from underrepresented groups, while stipulating that candidates cannot lead their own clinical trials but may participate in trials led by mentors. Interested applicants should note that the application deadline is January 7, 2028, and can find further details and guidelines in the full announcement available at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant designed to support postdoctoral fellows in their transition to independent research scientist roles at academic institutions. This grant aims to assist candidates in developing independent research programs and applying for regular research grants, with a focus on enhancing the scientific workforce in biomedical research, particularly in infectious diseases. Eligible applicants include higher education institutions, nonprofits, and government agencies, with funding of up to $150,000 available for the first year and up to $100,000 for the second year, requiring a full-time commitment of at least 75% effort to research activities. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2028.
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting senior postdoctoral fellows in their transition to independent research roles. This grant specifically targets candidates from diverse backgrounds, with the objective of fostering an inclusive research workforce and enhancing cancer research capabilities. The K22 award provides three years of salary and research funding, encouraging the development of independent research projects, particularly those leading to clinical trials. Interested applicants must adhere to NIH guidelines and submit their applications by January 7, 2028, with further details available at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Clinical Scientist Research Career Development Award (K08) to promote diversity in cancer research. This grant is aimed at individuals with clinical doctoral degrees from underrepresented backgrounds, providing them with protected research time and mentorship to enhance their capabilities in basic, behavioral, and translational cancer research. The program is designed to cultivate a diverse pool of qualified researchers to address the nation's health research needs and reduce disparities in cancer care and outcomes, with a maximum award duration of five years and a commitment of at least 75% of the candidate's time to career development activities. Interested applicants must submit their proposals by January 7, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Career Transition Award for NIMH Intramural Fellows (K22), designed to support the transition of qualified postdoctoral fellows from intramural research positions to tenure-track faculty roles at eligible U.S. institutions. This grant program consists of two mentored phases: an intramural phase lasting up to two years and an extramural phase lasting up to three years, aimed at fostering the development of independent research programs while allowing applicants to engage in clinical trials under mentorship. The award provides funding of up to $90,000 annually for PhD recipients and $100,000 for MD recipients, along with additional funds for research-related expenses, with a total project period not exceeding five years. Interested applicants can find more information and application guidelines at the NIH grants website, and should note that the application deadline is March 12, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.